Horn & Co. advised Vascular Biogenics Ltd. on the deal. Vascular Biogenics Ltd. completed the merger with Notable Labs and the sale of its IP assets....
Vascular Biogenics Ltd.’s Merger with Notable Labs
INX’s Investment Agreement with Republic
Horn & Co. advised INX on the deal. INX Digital Company, Inc., a regulated broker-dealer, ATS, and transfer agent based in the US, has reached an...
Scopio Labs’ Collaboration Agreement with Siemens Healthineers
Horn advised Scopio Labs on the deal. Scopio Labs completed the collaboration agreement with Siemens Healthineers to Distribute Full-Field Digital Cell Morphology Technology. Scopio Labs provides digital...
VBL Therapeutics’ Merger with Notable Labs
Horn & Co. represented VBL Therapeutics on the deal. VBL Therapeutics executed the merger with Notable Labs. The merger aims to create Nasdaq-listed, clinical-stage therapeutic platform company developing new...
Purple Biotech’s Acquisition of Immunorizon
Horn&Co. advised Immunorizon on the deal. Purple Biotech executed the acquisition of Immunorizon in consideration for up to $100 million. Purple Biotech Ltd. is a clinical-stage company...
INX Digital Company’s Joint Venture with SICPA
Horn & Co. advised The INX Digital Company on the deal. The INX Digital Company, Inc. executed a joint venture with SICPA SA in the field...
Kamari Pharma’s $8 Million Raising Fund
Horn & Co. advised Kamari Pharma on the deal. Kamari Pharma executed a joint venture agreement raising $8 million. Kamari Pharma is a biopharmaceutical company that is developing...
Diagnostic Robotics’ Series B Fundraising
Horn & Co. represented Diagnostic Robotics in the deal, Amit, Pollak, Matalon & Co. advised StageOne, Migdal Insurance, Clal Insurance and Bank Hapoalim on the transaction....
Prisma Photonics’ $20 Million Capital Raising
Horn & Co. advised Prisma Photonics on the deal. ERM advised Future Energy Ventures on the transaction. Prisma Photonics Ltd. executed a $20 million raise from Insight...
INX Digital Company’s Reverse Takeover
Horn & Co. advised INX Digital Company on the deal. INX Digital Company, Inc. closed its reverse takeover transaction. INX Digital Company Inc. which include regulated trading platforms for digital...
Emergence Therapeutics’ Series A Financing Round
ARQIS has advised biotech company Emergence Therapeutics AG on the deal, while Horn&Co. advised Pontifax Ventures 6. J&A advised Bpifrance. Weitnauer advised NRW.BANK. The round was...
Zebra Medical Vision’s $200 Million Merger with Nanox Vision
Horn & Co. advised Zebra Medical Vision on the deal. APM&Co represented NANO-X IMAGING Ltd on the deal. Zebra Medical Vision Ltd. executed a $200 million merger...